Cryptosporidiosis Clinical Trial
Official title:
Pilot Intervention Trial of Ceramic Water Filters to Reduce the Burden of Cryptosporidium in Household Drinking Water in Rural Kenya.
The aim of the study is to examine the efficacy of ceramic water filters to reduce the burden of waterborne diarrheal illness among infants in selected villages in Kenya. In Kenya very young children are given drinking water or water is used in reconstitution of their food. We hypothesize that ceramic water filters will remove Cryptosporidium from drinking water reducing infection in infants.
Status | Not yet recruiting |
Enrollment | 240 |
Est. completion date | |
Est. primary completion date | August 2013 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Both |
Age group | 4 Months to 10 Months |
Eligibility |
Inclusion Criteria: Children 4-10 months old living in selected villages in the Asembo Health and Demographic Surveillance System (HDSS) study area in Kenya whose primary caretakers consent on their behalf to be visited weekly for 6 months to carry out weekly illness surveillance, and have a follow up home visit one year after initial enrollment into the trial. The household in which the child resides must be a consenting participant in the HDSS. As the children included in the trial are infants, the child's primary caretaker will be invited to participate and be administered questionnaires. Random selection will be at the compound level. Only one household per compound will be eligible for selection. Exclusion Criteria: Children 4-10 months old whose households are not active consenting participants in the HDSS will not be eligible for inclusion. Only the subset of children 4-10 months old who are randomly selected in the sample will be eligible for participation. |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Centers for Disease Control and Prevention | Kenya Medical Research Institute |
Kenya,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Longitudinal diarrhea prevalence | The primary outcome measure is the longitudinal prevalence of diarrheal disease. | 6 months | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT00057486 -
Interleukin 12 (IL-12) for the Treatment of Cryptosporidiosis in AIDS Patients
|
Phase 1/Phase 2 | |
Completed |
NCT00507871 -
Transmission and the Respiratory Tract in Cryptosporidiosis
|
N/A | |
Terminated |
NCT00001162 -
Parasitic Infections of the Gastrointestinal Tract
|
N/A | |
Recruiting |
NCT05208970 -
Cryptosporidium Species in Sohag Governorate
|
||
Recruiting |
NCT04332705 -
Cryptosporidium Infection and Human Colorectal Cancer
|
||
Active, not recruiting |
NCT02764918 -
Cryptosporidiosis and Enteropathogens in Bangladesh
|
||
Terminated |
NCT00004986 -
Safety and Effectiveness of Nitazoxanide for the Treatment of Cryptosporidiosis in AIDS Patients
|
Phase 3 | |
Completed |
NCT04103216 -
Treatment of Cryptosporidiosis
|
N/A | |
Terminated |
NCT03341767 -
A Phase 2A Evaluation of the Safety, Tolerability, Pharmacokinetics, Efficacy of Clofazimine (CFZ) in Cryptosporidiosis
|
Phase 2 | |
Completed |
NCT01699841 -
Breast Milk Composition and HIV-exposed/Unexposed Early Infant Growth and Infectious Disease Events
|
N/A | |
Active, not recruiting |
NCT00002158 -
A Study to Evaluate the Use of Nitazoxanide to Treat Cryptosporidiosis
|
N/A | |
Completed |
NCT00002248 -
A Randomized, Multicenter, Double-Blind, Parallel-Group, Placebo-Controlled Trial of the Efficacy and Safety of Bovine Anti-Cryptosporidium Immunoglobulin (BACI) in the Treatment of Cryptosporidium Enteritis in AIDS Patients
|
Phase 1 | |
Terminated |
NCT00001128 -
Treatment of Chronic Cryptosporidiosis in AIDS Patients
|
N/A | |
Completed |
NCT00002328 -
Azithromycin in the Treatment of Cryptosporidiosis in Patients Who Have Not Had Success With Other Drugs
|
N/A | |
Completed |
NCT00001081 -
A Study of Nitazoxanide in Patients With AIDS and Diarrhea Caused by Cryptosporidium
|
Phase 2 | |
Completed |
NCT00002027 -
Protocol For the Treatment of Cryptosporidiosis in AIDS Patients With Diclazuril (R64,433)
|
N/A | |
Completed |
NCT00002278 -
A 28-Day Study of Diclazuril in the Treatment of Cryptosporidiosis in Patients With AIDS
|
N/A | |
Completed |
NCT00001018 -
A Study of Letrazuril in the Treatment of AIDS-Related Diarrhea
|
Phase 1 | |
Completed |
NCT00055107 -
Nitazoxanide for the Treatment of Chronic Diarrhea in HIV Infected Children
|
Phase 1/Phase 2 | |
Completed |
NCT00002264 -
The Effectiveness of Cow's Milk Immune Globulin in the Treatment of AIDS-Related Diarrhea
|
N/A |